1. Minimal Residual Disease and Hematologic Malignancies

3. Contents

4. MRD in Multiple Myeloma

5. Rationale for Measuring MRD in MM

6. Methods and Results

7. Implications for Clinical Practice

8. Emerging Approaches to Assess MRD

9. MRD in Acute Lymphoblastic Leukemia

10. MRD in ALL

11. MRD in ALL (cont)

12. MRD in Acute Myeloid Leukemia

13. Why Assess MRD in Patients With AML?

14. Methods of Assessing MRD in AML

15. What Prognostic Information Can MRD Potentially Provide?

16. Challenges and Questions

17. MRD in Chronic Lymphoblastic Leukemia

18. Testing Methods

19. Implications

20. Abbreviations

21. Abbreviations (cont)